These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Assessment of myocardial viability: review of the clinical significance. Ramos M; DePasquale E; Coplan NL Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580 [TBL] [Abstract][Full Text] [Related]
10. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. Allman KC; Shaw LJ; Hachamovitch R; Udelson JE J Am Coll Cardiol; 2002 Apr; 39(7):1151-8. PubMed ID: 11923039 [TBL] [Abstract][Full Text] [Related]
11. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS; JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983 [TBL] [Abstract][Full Text] [Related]
12. Assessment of myocardial viability in chronic left ventricular dysfunction. Ling LH; Tei C; Pellikka PA J Cardiol; 1995 Apr; 25(4):199-211. PubMed ID: 7752054 [TBL] [Abstract][Full Text] [Related]
14. The hibernating heart: reversible left ventricular dysfunction in chronic heart failure. Burn S; Walters M; Caplin J Postgrad Med J; 1999 Jul; 75(885):419-21. PubMed ID: 10474727 [TBL] [Abstract][Full Text] [Related]
15. [F-18 fluorodeoxyglucose for diagnosis of myocardial viability: applications in clinical practice]. Graf S; Porenta G Wien Med Wochenschr; 2002; 152(11-12):289-92. PubMed ID: 12138658 [TBL] [Abstract][Full Text] [Related]
16. Assessment of myocardial viability by nuclear imaging techniques. Bax JJ; Poldermans D; Elhendy A; Boersma E; van der Wall EE Curr Cardiol Rep; 2005 Mar; 7(2):124-9. PubMed ID: 15717959 [TBL] [Abstract][Full Text] [Related]
17. Clinical importance of viability assessment in chronic ischemic heart failure. Calhoun WB; Mills RM; Drane WE Clin Cardiol; 1996 May; 19(5):367-9. PubMed ID: 8723594 [TBL] [Abstract][Full Text] [Related]
18. [Percutaneous revascularization of chronic total occlusion of the left main coronary artery]. Secco GG; Marino PN; Venegoni L; De Luca G Rev Esp Cardiol; 2011 May; 64(5):431-3. PubMed ID: 21470759 [No Abstract] [Full Text] [Related]
19. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888 [TBL] [Abstract][Full Text] [Related]
20. Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease. Mc Ardle B; Shukla T; Nichol G; deKemp RA; Bernick J; Guo A; Lim SP; Davies RA; Haddad H; Duchesne L; Hendry P; Masters R; Ross H; Freeman M; Gulenchyn K; Racine N; Humen D; Benard F; Ruddy TD; Chow BJ; Mielniczuk L; DaSilva JN; Garrard L; Wells GA; Beanlands RS; Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]